2-(Piperazinyl)-4-pyrimioinamines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602433, 544284, 544291, 544295, A61K 31505

Patent

active

043339379

ABSTRACT:
Herein is disclosed 2-(1-piperazinyl)-4-pyrimidinamine derivatives, acid addition salts thereof, processes for their preparation, methods of using the derivatives and pharmaceutical compositions of the derivatives. The derivatives are distinguished most readily by having novel substituents at position 4 of the piperazinyl radical, the substituents being selected from the group consisting of optionally substituted 2-cycloheptimidazolyl, 1,4,5,6,7,8-hexahydrocycloheptimidazol-2-yl, 2-benzoxazolyl, benzthiazol-2-yl, 1H-2-benzimidazolyl and 1-oxo-2,4,6-cycloheptarien-2-yl. The derivatives are useful for treating hypertension in a mammal.

REFERENCES:
patent: 3511836 (1970-05-01), Hess
patent: 3935213 (1976-01-01), Hess
patent: 4001237 (1977-01-01), Partyka et al.
patent: 4093726 (1978-06-01), Winn et al.
Althuis et al., J. Med. Chem., 20, 146-149 (1977).
Derwent Publications Ltd., Farmdoe 36461B for Netherland Patent 7,804,135.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-(Piperazinyl)-4-pyrimioinamines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-(Piperazinyl)-4-pyrimioinamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(Piperazinyl)-4-pyrimioinamines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-552813

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.